The role of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) evaluation in pericardial fluid for the recognition of malignant pericarditis

International Journal of Biological Markers

Volumn 12, Issue 3, 1997, Pages 96-101

  Szturmowicz, M ^a   Tomkowski, W ^a   Fijalkowska, A ^a   Burakowski, J ^a   Sakowicz, A ^a   Filipecki, S ^a  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

Carcinoembryonic antigen; Cardiac tamponade; Cytologic examination; Differential diagnosis; Neuron specific enolase; Pericardial effusion; Pericarditis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; NEURON SPECIFIC ENOLASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOLOGY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDITIS; RADIOIMMUNOASSAY;

EID: 0031461072     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460089701200302     Document Type: Article

References (31)

1. Hancock EW. Neoplastic pericardial disease. Cardiol Clin 1990; 8: 673-82.
2. Olsen PS, Sorensen C, Andersen HO. Surgical treatment of large pericardial effusions. Etiology and long-term survival. Eur J Cardio-thorac Surg 1991; 5: 430-2.
3. Colombo A, Olson HG, Egan J, Gardin JM. Etiology and prognostic implications of a large pericardial effusion in men. Clin Cardiol 1988; 11: 389-94.
4. Press OW, Livingston R. Management of malignant pericardial effusion and tamponade. JAMA 1987; 257: 1088-92.
5. Posner MR, Cohen GI, Skarin AT. Pericardial disease in patients with cancer. The differentiation of malignant from idiopathic and radiation-induced pericarditis. Am J Med 1981; 71: 407-13.
6. Okamoto H, Shinkai T, Yamakido M, Saijo N. Cardiac tamponade caused by primary lung cancer and the management of pericardial effusion. Cancer 1993; 71: 93-8.
7. Muir KW, Rodger JC. Cardiac tamponade as the initial presentation of malignancy: is it as rare as previously supposed? Postgrad Med J 1994; 70: 703-7.
8. Vaitkus PT, Herrmann HC, LeWinter MM. Treatment of malignant pericardial effusion. JAMA 1994; 272: 59-64.
9. Moores DW, Dziuban SW Jr. Pericardial drainage procedures. Chest Sur Clin N Am 1995; 5: 359-73.
10. Cooper JP, Oliver RM, Currie P, Walker JM, Swanton RH. How do the clinical findings in patients with pericardial effusions influence the success of aspiration? Br Heart J 1995; 73: 351-4.
11. Kohnoe S, Maehara Y, Takahashi I, Saito A, Okada Y, Sugimachi K. Intrapericardial mitomycin C for the management of malignant pericardial effusion secondary to gastric cancer: case report and review. Chemotherapy 1994; 40: 57-60.
12. Tondini M, Rocco G, Bianchi C, Seven C, Corbellini D. Intracavitary cisplatin (CDDP) in the treatment of metastatic pericardial involvement from breast and lung cancer. Monaldi Arch Chest Dis 1995; 50: 86-8.
13. Tomkowski W, Szturmowicz M, Fijalkowska A, Filipecki S, Figura-Chojak E. Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion. J Cancer Res Clin Oncol 1994; 120: 434-6.
14. Fiorentino MV, Daniele O, Morandi P, et al. Intrapericardial instillation of platin in malignant pericardial effusion. Cancer 1988; 62: 1904-6.
15. Tomkowski W, Szturmowicz M, Fijalkowska A, Burakowski J, Filipecki S. New approaches to the management and treatment of malignant pericardial effusion. Support Care Cancer 1997; 5: 64-6.
16. Wiener HG, Kristensen IB, Haubek A, Kristensen B, Baandrup U. The diagnostic value of pericardial cytology. An analysis of 95 cases. Acta Cytol 1991; 35: 149-53.
17. Haskell RJ, French WJ. Cardiac tamponade as the initial presentation of malignancy. Chest 1985; 88: 70-3.
18. Fraser RS, Viloria JB, Wang NS. Cardiac tamponade as a presentation of extracardiac malignancy. Cancer 1980; 45: 1697-704.
19. Kralstein J, Frishman W. Malignant pericardial diseases: diagnosis and treatment. Am Heart J 1987; 113: 785-90.
20. Ferrigno D, Buccheri G. Clinical applications of serum markers for lung cancer. Respir Med 1995; 89: 587-97.
21. Bardales RH, Stanley MW, Schaefer RF, Liblit RL, Owens RB, Surhland MJ. Secondary pericardial malignancies. A critical appraisal of the role of cytology, pericardial biopsy, and DNA ploidy analysis. Am J Clin Pathol 1996; 106: 29-34.
22. Lopez JM, Delgado JL, Tovar E, Gonzales AG. Massive pericardial effusion produced by extracardiac malignant neoplasms. Arch Intern Med 1983; 143: 1815-6.
23. Edoute Y, Malberger E, Kuten A, Ben-Haim SA, Moscovitz M. Cytologic analysis of pericardial effusion complicating extracardiac malignancy. Am J Cardiol 1992; 69: 568-71.
24. Pinto MM. Malignant pericardial effusion and cardiac tamponade. Acta Cytol 1986; 30: 657-61.
25. Tatsuta M, Yamamura H, Yamamoto R, Ichii M, Iishi A, Noguchi S. Carcinoembryonic antigens in the pericardial fluid of patients with malignant pericarditis. Oncology 1984; 41: 328-30.
26. Koh KK, Kim EJ, Cho CH, et al. Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis. Circulation 1994; 89: 2728-35.
27. Marel M, Stastny B, Melinova L, Svandova E, Light RW. Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990. Chest 1995; 107: 1598-603.
28. Botte G, Laferrere L, Etchepare S, Dalurzo D, Duhart JE, Adaro FV. Diagnostic value of tumor markers in pleural effusions. Medicina B. Aires 1990; 50: 213-6.
29. Ochnio J, Rowinska-Zakrzewska E, Szymanska D, Traczyk K, Roginska E, Kwiek S. Determination of CEA in pleural fluid in the differential diagnosis of pleural exudates-preliminary report. Pol Tyg Lek 1985; 40: 729-32.
30. Yagi S. Clinical evaluation of pleural effusion-carcinoembryonic antigen (CEA) and adenosine deaminase (ADA) activities in pleural fluids. Kekkaku 1990; 65: 775-83.
31. Shijubo N, Honda Y, Fujishima T, et al. Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma. Eur Respir J 1995; 8: 403-6.